BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16226808)

  • 1. Uptake and metabolic effects of insulin mimetic oxovanadium compounds in human erythrocytes.
    Delgado TC; Tomaz AI; Correia I; Costa Pessoa J; Jones JG; Geraldes CF; Castro MM
    J Inorg Biochem; 2005 Dec; 99(12):2328-39. PubMed ID: 16226808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N,N'-ethylenebis(pyridoxylideneiminato) and N,N'-ethylenebis(pyridoxylaminato): synthesis, characterization, potentiometric, spectroscopic, and DFT studies of their vanadium(IV) and vanadium(V) complexes.
    Correia I; Costa Pessoa J; Duarte MT; Henriques RT; Piedade MF; Veiros LF; Jakusch T; Kiss T; Dörnyei A; Castro MM; Geraldes CF; Avecilla F
    Chemistry; 2004 May; 10(9):2301-17. PubMed ID: 15112220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones. Rationalization of the influence of basicity and electronic structure of the ligand on the properties of V(IV)O species in aqueous solution.
    Rangel M; Leite A; João Amorim M; Garribba E; Micera G; Lodyga-Chruscinska E
    Inorg Chem; 2006 Oct; 45(20):8086-97. PubMed ID: 16999406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of hydroxyurea with oxovanadium(V) ions in acidic aqueous solution.
    Gabricević M; Besić E; Birus M; Zahl A; Eldik Rv
    J Inorg Biochem; 2006 Oct; 100(10):1606-13. PubMed ID: 16842853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of p-chlorotoluene and cyclohexene catalysed by polymer-anchored oxovanadium(IV) and copper(II) complexes of amino acid derived tridentate ligands.
    Maurya MR; Kumar M; Kumar A; Costa Pessoa J
    Dalton Trans; 2008 Aug; (32):4220-32. PubMed ID: 18682861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model investigations for vanadium-protein interactions: vanadium(III) compounds with dipeptides and their oxovanadium(IV) analogues.
    Tasiopoulos AJ; Tolis EJ; Tsangaris JM; Evangelou A; Woollins D; Slawin AM; Pessoa C; Correia I; Kabanos TA
    J Biol Inorg Chem; 2002 Apr; 7(4-5):363-74. PubMed ID: 11941494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiometric, spectroscopic, electrochemical and DFT characterization of oxovanadium(IV) complexes formed by citrate and tartrates in aqueous solution at high ligand to metal molar ratios: the effects of the trigonal bipyramidal distortion in bis-chelated species and biological implications.
    Lodyga-Chruscinska E; Sanna D; Garribba E; Micera G
    Dalton Trans; 2008 Sep; (36):4903-16. PubMed ID: 18766223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
    Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
    J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
    Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
    J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.
    Xie MJ; Yang XD; Liu WP; Yan SP; Meng ZH
    J Inorg Biochem; 2010 Aug; 104(8):851-7. PubMed ID: 20434776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic properties, redox behavior, and interactions with H2O2 of pH-sensitive hydroxyphenyl-1,2,4-triazole-based oxovanadium(V) complexes.
    Browne WR; Ligtenbarg AG; de Boer JW; van den Berg TA; Lutz M; Spek AL; Hartl F; Hage R; Feringa BL
    Inorg Chem; 2006 Apr; 45(7):2903-16. PubMed ID: 16562946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, spectroscopic characterization and reactivity studies of oxovanadium(IV) complexes with bulky N,N'-polymethylenebis(3,5-(t)Bu(2)salicylaldimine) ligands.
    Kasumov VT; Köksal F; Aslanoglu M; Yerli Y
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Oct; 77(3):630-7. PubMed ID: 20674475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the binding of oxovanadium(IV) to human serum albumin.
    Correia I; Jakusch T; Cobbinna E; Mehtab S; Tomaz I; Nagy NV; Rockenbauer A; Pessoa JC; Kiss T
    Dalton Trans; 2012 Jun; 41(21):6477-87. PubMed ID: 22476413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes.
    Maurya MR; Agarwal S; Abid M; Azam A; Bader C; Ebel M; Rehder D
    Dalton Trans; 2006 Feb; (7):937-47. PubMed ID: 16462954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds: pyridine-2,6-dicarboxylatodioxovanadium(V), BMOV, and an amavadine analogue.
    Aureliano M; Henao F; Tiago T; Duarte RO; Moura JJ; Baruah B; Crans DC
    Inorg Chem; 2008 Jul; 47(13):5677-84. PubMed ID: 18510311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
    Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
    J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural study of the interaction of vanadate with the ligand 1,2-dimethyl-3-hydroxy-4-pyridinone (Hdmpp) in aqueous solution.
    Castro MM; Geraldes CF; Gameiro P; Pereira E; Castro B; Rangel M
    J Inorg Biochem; 2000 May; 80(1-2):177-9. PubMed ID: 10885483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxovanadium(IV)-catalysed oxidation of dibenzothiophene and 4,6-dimethyldibenzothiophene.
    Ogunlaja AS; Chidawanyika W; Antunes E; Fernandes MA; Nyokong T; Torto N; Tshentu ZR
    Dalton Trans; 2012 Dec; 41(45):13908-18. PubMed ID: 23023479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the antidiabetic capacity of the VO(dmpp)2 complex.
    Passadouro M; Metelo AM; Melão AS; Pedro JR; Faneca H; Carvalho E; Castro MM
    J Inorg Biochem; 2010 Sep; 104(9):987-92. PubMed ID: 20627316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vanadium(V) compounds with the bis-(hydroxylamino)-1,3,5-triazine ligand, H2bihyat: synthetic, structural, and physical studies of [V2(V)O3(bihyat)2] and of the enhanced hydrolytic stability species cis-[V(V)O2(bihyat)]-.
    Nikolakis VA; Tsalavoutis JT; Stylianou M; Evgeniou E; Jakusch T; Melman A; Sigalas MP; Kiss T; Keramidas AD; Kabanos TA
    Inorg Chem; 2008 Dec; 47(24):11698-710. PubMed ID: 19006295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.